Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy

Published on Sep 20, 2016in Journal of the American College of Cardiology20.589
· DOI :10.1016/J.JACC.2016.06.056
Alexander C. Egbe20
Estimated H-index: 20
(Mayo Clinic),
Heidi M. Connolly75
Estimated H-index: 75
(Mayo Clinic)
+ 6 AuthorsDavid J. Driscoll71
Estimated H-index: 71
(Mayo Clinic)
Sources
Abstract
Abstract Background There are limited data about the risk of thrombotic and embolic complication (TEC) in adults with atrial arrhythmia after Fontan operation. Objectives This study sought to determine the risk of TEC in this population and the role of anticoagulation therapy in TEC prevention. Methods This was a retrospective review of adults with atrial arrhythmia after Fontan operation who were evaluated at the Mayo Clinic between 1994 to 2014. TEC was classified into 2 groups: systemic TEC, defined as intracardiac thrombus, ischemic stroke, or systemic arterial embolus; and nonsystemic TEC, defined as Fontan conduit/right atrial thrombus or pulmonary embolus. Patients were divided into 3 groups: anticoagulation, antiplatelet, and no therapy cohorts. Results We followed 278 patients, mean age 31 ± 9 years, for 88 ± 14 months (1,464 patient-years). Patient groups included antiplatelet (n = 181), anticoagulation (n = 91), and no therapy (n = 6). There were 97 TEC in 81 patients (29%); 32 were systemic, yielding an event rate of 2.1 systemic TEC per 100 patient-years, and 65 were nonsystemic TEC, yielding an event rate of 4.4 nonsystemic TEC per 100 patient-years. Prevalence of TEC was 18% and 55% at 5 and 10 years, respectively. Atriopulmonary connection was a risk factor for TEC (hazard ratio: 2.31; 95% confidence interval: 1.61 to 4.64), and TEC were associated with higher risk of death and hospitalization (p  Conclusions Anticoagulation was associated with lower TEC rate and lower risk of death and hospitalization, without a significant increase in bleeding risk. Perhaps anticoagulation should be the preferred preventive strategy.
Figures & Tables
Download
📖 Papers frequently viewed together
293 Citations
189 Citations
200823.60Circulation
697 Citations
References27
Newest
#1Kavitha N. Pundi (Mayo Clinic)H-Index: 8
#2Jonathan N. Johnson (Mayo Clinic)H-Index: 30
Last. Frank Cetta (Mayo Clinic)H-Index: 46
view all 11 authors...
Background There are limited long-term, single-cohort, follow-up studies available about patients after the Fontan operation. Objectives This study sought to determine the long-term outcome of all patients who had a Fontan operation at the Mayo Clinic. Methods Records of all patients who had a modified Fontan operation between 1973 and 2012 were reviewed. A follow-up questionnaire was mailed to all patients alive at the time of the study. Results Overall, 10-, 20-, and 30-year survival for 1,052...
293 CitationsSource
#1Koichi Sughimoto (Royal Children's Hospital)H-Index: 9
#2Kazuki Okauchi (Hitachi)H-Index: 1
Last. Ken-ichi Tsubota (Chiba University)H-Index: 20
view all 8 authors...
The classical Fontan route, namely the atriopulmonary connection (APC), continues to be associated with a risk of thrombus formation in the atrium. A conversion to a total cavopulmonary connection (TCPC) from the APC can ameliorate hemodynamics for the failed Fontan; however, the impact of these surgical operations on thrombus formation remains elusive. This study elucidates the underlying mechanism of thrombus formation in the Fontan route by using a two-dimensional computer hemodynamic simulat...
9 CitationsSource
#1Mi Kyoung Song (SNU: Seoul National University)H-Index: 8
#2Eun Jung Bae (SNU: Seoul National University)H-Index: 20
Last. Yong Jin Kim (SNU: Seoul National University)H-Index: 15
view all 9 authors...
Abstract Background : Atrial tachyarrhythmia is a major late complication in adult Fontan patients. This study examined the clinical features and risk factors of late intra-atrial reentrant tachyarrhythmia (IART) in adult patients after Fontan surgery and the mid-term outcome of Fontan conversion with or without antiarrhythmic surgery in these patients. Methods : We conducted a retrospective study on adult patients who were born before 1994 and survived at least 3months after a Fontan operation ...
22 CitationsSource
#1Nida Yousef (Boston Children's Hospital)H-Index: 1
#2Molly Philips (Boston Children's Hospital)H-Index: 1
Last. David A. Roberson (Boston Children's Hospital)H-Index: 17
view all 6 authors...
Transesophageal echocardiography (TEE) is used in atrial flutter or fibrillation (AFF) before electric cardioversion to detect intracardiac thrombi. Previous studies have described the use of TEE to diagnose intracardiac thrombi in the left atrium and left atrial appendage, which has an incidence of 8 % among patients without congenital heart disease (CHD). In their practice the authors have noted a significant incidence of intracardiac thrombi in other structures of patients with CHD and AFF. T...
6 CitationsSource
Objectives Continuous flow in the Fontan circulation results in impairment of pulmonary artery endothelial function, increased pulmonary arterial resistance, and, potentially, late failure of Fontan circulation. We investigated the mechanisms of vascular remodeling and altered vascular reactivity associated with chronic privation of pulsatility on pulmonary vasculature. Methods A total of 30 pigs were evenly distributed in 3 groups: 10 underwent a sham procedure (group I) and 20 underwent a cavo...
63 CitationsSource
#1Jasmine Grewal (UBC: University of British Columbia)H-Index: 22
#3Jaimee Feldstein (UBC: University of British Columbia)H-Index: 1
Last. Jonathon Leipsic (UBC: University of British Columbia)H-Index: 98
view all 6 authors...
Background Thromboembolic complications have been noted after the Fontan operation. However, the prevalence of silent events among an adult contemporary population is not known. Noninvasive screening by any method including computed tomography (CT) has been technically limited to date. Objectives The objective of this study was to evaluate a novel dual-energy CT (DECT) protocol in determining the prevalence of “silent” intracardiac thrombus and thrombus in the Fontan and pulmonary circulations a...
32 CitationsSource
#1Paul Monagle (Royal Children's Hospital)H-Index: 61
#2Andrew D. Cochrane (Royal Children's Hospital)H-Index: 38
Last. Brian W. McCrindle (U of T: University of Toronto)H-Index: 114
view all 9 authors...
Objectives The purpose of this study was to compare the safety and efficacy of acetylsalicylic acid (ASA) and warfarin for thromboprophylaxis after the Fontan procedure. Background Fontan surgery is the definitive palliation for children with single-ventricle physiology. Thrombosis is an important complication; the optimal thromboprophylaxis strategy has not been determined. Methods We performed a multicenter international randomized trial of primary prophylactic anticoagulation after Fontan sur...
170 CitationsSource
#1Bemigho EtuweweH-Index: 1
#2Jasveer Mangat (Boston Children's Hospital)H-Index: 1
Last. Ed Ladusans (Boston Children's Hospital)H-Index: 1
view all 3 authors...
To the Editor, We read with great interest the recent publication by Anderson et al. [1] on the inconsistencies in medication therapy among Fontan patients across seven pediatric heart networks in the United States. The practice in the United Kingdom appears to reflect a similar treatment dilemma. We conducted a survey of consultant pediatric cardiologists, with 20 respondents representing 13 different pediatric cardiology centers in the United Kingdom. The main variation in practice was that 80...
5 CitationsSource
#1Chiara MarroneH-Index: 4
#2Gennaro GalassoH-Index: 29
Last. Giuseppe SantoroH-Index: 21
view all 7 authors...
The benefits of prophylactic anticoagulation or antiplatelet therapy for patients undergoing extracardiac conduit (ECC) Fontan procedure still are a matter of debate. Through a systematic review and meta-analysis, this study aimed to determine the incidence of thromboembolism among patients undergoing ECC Fontan who received anticoagulation or antiplatelet therapy. Until February 2010, MEDLINE studies describing the incidence of thromboembolic events after ECC Fontan were reviewed. Information o...
49 CitationsSource
#2Jeffrey P. Jacobs (USF: University of South Florida)H-Index: 87
Last. Robert H. Anderson (GOSH: Great Ormond Street Hospital)H-Index: 52
view all 15 authors...
Clinicians working in the field of congenital and paediatric cardiology have long felt the need for a common diagnostic and therapeutic nomenclature and coding system with which to classify patients of all ages with congenital and acquired cardiac disease. A cohesive and comprehensive system of nomenclature, suitable for setting a global standard for multicentric analysis of outcomes and stratification of risk, has only recently emerged, namely, The International Paediatric and Congenital Cardia...
133 CitationsSource
Cited By48
Newest
#1Andrea Girnius (University of Cincinnati Academic Health Center)H-Index: 1
#2Dominica Zentner (University of Melbourne)H-Index: 12
Last. Gruschen R. VeldtmanH-Index: 33
view all 30 authors...
Background/objectives: Pregnancy may potentiate the inherent hypercoagulability of the Fontan circulation, thereby amplifying adverse events. This study sought to evaluate thrombosis and bleeding risk in pregnant women with a Fontan. Methods: We performed a retrospective observational cohort study across 13 international centres and recorded data on thrombotic and bleeding events, antithrombotic therapies and pre-pregnancy thrombotic risk factors. Results: We analysed 84 women with Fontan physio...
1 CitationsSource
#1Yoshihiko KodamaH-Index: 1
#2Shinichiro OdaH-Index: 6
Last. Koichi SagawaH-Index: 7
view all 13 authors...
Source
#1Eman Abdelghani (Nationwide Children's Hospital)
#2Clifford L. Cua (Nationwide Children's Hospital)H-Index: 21
Last. Vilmarie Rodriguez (Nationwide Children's Hospital)
view all 4 authors...
Thrombosis is one of the most frequent complications affecting children with congenital heart disease (CHD). Palliative and reparative cardiac surgeries are some of the main players contributing to the thrombosis risk in this patient population. Additional risk factors related to the CHD itself (e.g., cardiac dysfunction, arrhythmias, and polycythemia in cyanotic cardiac disorders) can contribute to thrombogenicity alone or combined with other factors. Thrombotic complications have been recogniz...
Source
#1Iqbal El Assaad (Boston Children's Hospital)H-Index: 1
#2Tony Pastor (Boston Children's Hospital)
Last. Douglas Y. Mah (Boston Children's Hospital)H-Index: 14
view all 10 authors...
Background null Transvenous permanent pacemaker (PPM) implantation is an available option for Fontan patients with sinus node dysfunction. However, the thrombogenic potential of leads within the Fontan baffle is unknown. null null null Objective null The purpose of this study was to compare the clot burden in Fontan patients with a transvenous atrial PPM to those without a PPM and those with an epicardial PPM. null null null Methods null This was a retrospective cohort study of all transvenous P...
Source
#1Alexander C. Egbe (Mayo Clinic)H-Index: 20
#2William R. Miranda (Mayo Clinic)H-Index: 14
Last. Heidi M. Connolly (Mayo Clinic)H-Index: 75
view all 15 authors...
Abstract Background Total cavopulmonary connection (TCPC) is associated with a lower risk of incident atrial arrhythmias as compared to atriopulmonary Fontan, but the risk of recurrent atrial arrhythmias is unknown in this population. The purpose of this study was to determine the incidence and risk factors for recurrent atrial arrhythmias and thromboembolic complications in patients with TCPC. Methods This is a retrospective multicenter study conducted by the Alliance for Adult Research in Cong...
Source
#1Christoph SinningH-Index: 20
#2E. ZenginH-Index: 8
Last. Paulus KirchhofH-Index: 108
view all 7 authors...
Source
The number of Fontan patients with circulatory failure and systolic dysfunction is growing rapidly. The last decade has demonstrated that ventricular assist device (VAD) is an effective therapy in properly selected patients. Herein, we discuss the current approach to patient selection, implantation, and patient management.
Source
#1C. Karsenty (University of Toulouse)H-Index: 4
#2Victor Waldmann (Paris V: Paris Descartes University)H-Index: 10
Last. Magalie Ladouceur (Paris V: Paris Descartes University)H-Index: 21
view all 5 authors...
Despite impressive improvement in long-term survival, adults with congenital heart disease (CHD) remain exposed to a significant cardiovascular morbidity over lifetime. Thromboembolic events (TE) are a major issue. Specific anatomic groups have been shown a particular high risk of TE, including cyanotic heart disease and Fontan circulation. Many intercurrent clinical factors add a substantial risk such as intracardiac medical devices, atrial arrhythmia, endocarditis, or pregnancy. Nevertheless, ...
1 CitationsSource
#2Rahul H. Rathod (Boston Children's Hospital)H-Index: 18
Last. Gruschen R. VeldtmanH-Index: 33
view all 6 authors...
The authors summarize the most important anatomic and physiologic substrates of Fontan circulation. Common anatomic substrates include hypoplastic left heart syndrome, tricuspid atresia, double inlet left ventricle, and unbalanced atrioventricular septal defects. After the Fontan operation exercise capacity is limited and the key hemodynamic drivers is limited preload due to a relatively fixed pulmonary vascular resistance. The authors provide contemporary data on survival, morbidity, and need f...
Source
#1Diamantis Kosmidis (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 1
#2Alexandra Arvanitaki (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 6
Last. George Giannakoulas (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 19
view all 5 authors...
Abstract The Fontan procedure has evolved into the treatment of choice for infants with single ventricle physiology. The procedure and its modifications have extended survival of such patients into adulthood. However, adult patients face late complications, of which thromboembolic events (TEE) are considered complex and challenging in pathophysiology and management. All three components of Virchow's triad are affected in Fontan circulation. Remarkably, thromboembolic risk varies among the differ...
Source